Efficacy and Tolerability of First Line Arsenic Trioxide in Combination With All-Trans Retinoic Acid in Patients With Acute Promyelocytic Leukemia: Real Life Experience.

MLA

Autore, Francesco, et al. “Efficacy and Tolerability of First Line Arsenic Trioxide in Combination With All-Trans Retinoic Acid in Patients With Acute Promyelocytic Leukemia: Real Life Experience.” Frontiers in Oncology, vol. 11, July 2021, p. 614721. EBSCOhost, https://doi.org/10.3389/fonc.2021.614721.

APA

Autore, F., Chiusolo, P., Sorà, F., Giammarco, S., Laurenti, L., Innocenti, I., Metafuni, E., Piccirillo, N., Pagano, L., & Sica, S. (2021). Efficacy and Tolerability of First Line Arsenic Trioxide in Combination With All-Trans Retinoic Acid in Patients With Acute Promyelocytic Leukemia: Real Life Experience. Frontiers in Oncology, 11, 614721. https://doi.org/10.3389/fonc.2021.614721

Chicago

Autore, Francesco, Patrizia Chiusolo, Federica Sorà, Sabrina Giammarco, Luca Laurenti, Idanna Innocenti, Elisabetta Metafuni, Nicola Piccirillo, Livio Pagano, and Simona Sica. 2021. “Efficacy and Tolerability of First Line Arsenic Trioxide in Combination With All-Trans Retinoic Acid in Patients With Acute Promyelocytic Leukemia: Real Life Experience.” Frontiers in Oncology 11 (July): 614721. doi:10.3389/fonc.2021.614721.